<code id='905840914D'></code><style id='905840914D'></style>
    • <acronym id='905840914D'></acronym>
      <center id='905840914D'><center id='905840914D'><tfoot id='905840914D'></tfoot></center><abbr id='905840914D'><dir id='905840914D'><tfoot id='905840914D'></tfoot><noframes id='905840914D'>

    • <optgroup id='905840914D'><strike id='905840914D'><sup id='905840914D'></sup></strike><code id='905840914D'></code></optgroup>
        1. <b id='905840914D'><label id='905840914D'><select id='905840914D'><dt id='905840914D'><span id='905840914D'></span></dt></select></label></b><u id='905840914D'></u>
          <i id='905840914D'><strike id='905840914D'><tt id='905840914D'><pre id='905840914D'></pre></tt></strike></i>

          knowledge

          knowledge

          author:focus    Page View:47
          Calling Bullshit course University of Washington
          Screenshot via callingbullshit.org

          Tired of alternative facts, fake news, and breathless hyperbole, two professors at the University of Washington are trying to strike a blow for science.

          Their weapon? A new course: “Calling Bullshit In the Age of Big Data.”

          advertisement

          The class website and colorful syllabus went online last month and almost instantly went viral.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Hepatitis C has a cure — but many Americans still lack access to it
          Hepatitis C has a cure — but many Americans still lack access to it

          AdobeIn2005,NickVoyleswasdiagnosedwithhepatitisCafterbeingreleasedfromfiveyearsofincarceration.Anurs

          read more
          The biotech scorecard for Q3: 15 stock
          The biotech scorecard for Q3: 15 stock

          RyanPierse/GettyImagesHereisSTAT’sbiotechscorecard,ourregularledgerofstock-movingbiotechevents,forth

          read more
          Medical records are filled with copy
          Medical records are filled with copy

          AdobeIrecentlytookcareofapatientwhosemedicalrecordsincludedmultiplenotesaboutherpastopen-heartsurger

          read more

          Dexcom's push to bring CGM to type 2 diabetes patients

          KevinSayer,CEOofDexcomDexcomForyears,diabetestechcompanyDexcomhasbeenstrivingtogetitscontinuousgluco